Anti-TGFB2/ G-TSF/ LDS4 functional antibody

Anti-TGFB2/ G-TSF/ LDS4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TGFB2/TGFB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T14143-Ab-1/ GM-Tg-hg-T14143-Ab-2Anti-Human TGFB2 monoclonal antibodyHuman
GM-Tg-rg-T14143-Ab-1/ GM-Tg-rg-T14143-Ab-2Anti-Rat TGFB2 monoclonal antibodyRat
GM-Tg-mg-T14143-Ab-1/ GM-Tg-mg-T14143-Ab-2Anti-Mouse TGFB2 monoclonal antibodyMouse
GM-Tg-cynog-T14143-Ab-1/ GM-Tg-cynog-T14143-Ab-2Anti-Cynomolgus/ Rhesus macaque TGFB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T14143-Ab-1/ GM-Tg-felg-T14143-Ab-2Anti-Feline TGFB2 monoclonal antibodyFeline
GM-Tg-cang-T14143-Ab-1/ GM-Tg-cang-T14143-Ab-2Anti-Canine TGFB2 monoclonal antibodyCanine
GM-Tg-bovg-T14143-Ab-1/ GM-Tg-bovg-T14143-Ab-2Anti-Bovine TGFB2 monoclonal antibodyBovine
GM-Tg-equg-T14143-Ab-1/ GM-Tg-equg-T14143-Ab-2Anti-Equine TGFB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T14143-Ab-1/ GM-Tg-hg-T14143-Ab-2; GM-Tg-rg-T14143-Ab-1/ GM-Tg-rg-T14143-Ab-2;
GM-Tg-mg-T14143-Ab-1/ GM-Tg-mg-T14143-Ab-2; GM-Tg-cynog-T14143-Ab-1/ GM-Tg-cynog-T14143-Ab-2;
GM-Tg-felg-T14143-Ab-1/ GM-Tg-felg-T14143-Ab-2; GM-Tg-cang-T14143-Ab-1/ GM-Tg-cang-T14143-Ab-2;
GM-Tg-bovg-T14143-Ab-1/ GM-Tg-bovg-T14143-Ab-2; GM-Tg-equg-T14143-Ab-1/ GM-Tg-equg-T14143-Ab-2
Products NameAnti-TGFB2 monoclonal antibody
Formatmab
Target NameTGFB2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TGFB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-889Pre-Made Lerdelimumab Biosimilar, Whole Mab, Anti-Tgfb2 Antibody: Anti-G-TSF/LDS4/TGF-beta2 therapeutic antibody
    Target AntigenGM-Tg-g-T14143-Ag-1Recombinant multi-species TGFB2/ G-TSF/ LDS4 protein
    CytokineGM-Tg-g-T14143-Ag-1transforming growth factor, beta 2 (TGFB2) protein
    ORF Viral VectorvGMAP000588Human TGFB2 Adenovirus particle
    ORF Viral VectorvGMLV000388human TGFB2 Lentivirus particle
    ORF Viral VectorpGMAP000588Human TGFB2 Adenovirus plasmid
    ORF Viral VectorpGMLV000388human TGFB2 Lentivirus plasmid


    Target information

    Target IDGM-T14143
    Target NameTGFB2
    Gene ID7042,21808,81809,707540,488596,101093414,534069,100050377
    Gene Symbol and SynonymsG-TSF,LDS4,MGF,TGF-B2,TGF-beta2,Tgfb-2,TGFB2,TGFbeta2
    Uniprot AccessionP61812,Q07257,P21214
    Uniprot Entry NameTGFB2_HUMAN,TGFB2_RAT,TGFB2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000092969
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: TGFB2, gene name: TGFB2, also named as G-TSF, LDS4, TGF-beta2. This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.